A "field change" of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma

Journal of Clinical Pathology

Volumn 59, Issue 9, 2006, Pages 942-946

  Badvie, S ^a   Hanna Morris, A ^a   Andreyev, H J N ^a   Cohen, P ^b   Saini, S ^a   Allen Mersh, T G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROTEIN BCL XL;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL COUNT; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; DEMOGRAPHY; DIVERTICULOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECTUM PROLAPSE; VOLVULUS;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-X PROTEIN; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 33748859701     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.033431     Document Type: Article

References (12)

1. Deschner EE. Kinetics of normal, preneoplastic and neoplastic colon epithelium. San Diego: Academic Press, 1990:41.
2. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-Myc to immortalize pre-B cells. Nature 1988;335:440-2.
3. Boise LH, Gonzalez-Garzia M, Postema CE, et al. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-008.
4. Terpstra OT, Van Blankenstein M, Dees J, et al. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987;92:704-8.
5. Ponz de Leon M, Roncucci L, DiDonato P, et al. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res 1988;48:4121-6.
6. Wilson RG, Smith AN, Bird CC. Immunohistochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps. J Clin Pathol 1990;43:744-7.
7. Potten CS, Kellett M, Rew D, et al. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo; data for different sites, proximity to a tumour, and polyposis coli. Cut 1992;33:524-9.
8. American Joint Committee on Cancer. Colon and rectum. AJCC cancer staging manual. 6th edn. New York: Springer, 2002:113-24.
9. Backus HHJ, Van Groeningen CJ, Vos W, et al. Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours and liver metastases. J Clin Pathol 2002;55:206-11.
10. Maurer CA, Friess H, Buhler SS, et al. Apoptosis inhibiting factor Bcl-xL might be the crucial member of the Bcl-2 gene family in colorectal cancer. Dig Dis Sci 1998;43:2641-8.
11. Lyles CM, Sandler RS, Keku TO, et al. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry. Cancer Epidemiol Biomarkers Prev 1994;3:597-605.
12. Mills SJ, Mathers JC, Chapman PD, et al. Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut 2001;48:41-6.